We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
+12.79%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$45.5B
AUM Growth
+$3.87B
Cap. Flow
-$3.11B
Cap. Flow %
-6.83%
Top 10 Hldgs %
22.97%
Holding
2,251
New
17
Increased
879
Reduced
1,035
Closed
90

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$59.4M
2
AMZN icon
Amazon
AMZN
+$52.3M
3
CRH icon
CRH
CRH
+$29.3M
4
KVUE icon
Kenvue
KVUE
+$28.9M
5
MA icon
Mastercard
MA
+$27.4M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$968M
2
NTES icon
NetEase
NTES
+$689M
3
RYAAY icon
Ryanair
RYAAY
+$518M
4
PDD icon
Pinduoduo
PDD
+$419M
5
ATVI
Activision Blizzard
ATVI
+$59.1M

Sector Composition

Rank Sector Weight
1 Technology 28.06%
2 Financials 12.85%
3 Healthcare 12.76%
4 Consumer Discretionary 11.54%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
1801
Revolution Medicines
RVMD
$44.4B
$255K ﹤0.01%
8,950
+2,294
+34% +$55.1K
IMVT icon
1802
Immunovant
IMVT
$8.24B
$251K ﹤0.01%
5,987
+845
+16% +$31.1K
STRL icon
1803
Sterling Infrastructure
STRL
$16.2B
$251K ﹤0.01%
2,877
SCM icon
1804
Stellus Capital Investment Corp
SCM
$245M
$250K ﹤0.01%
19,568
-2,119
-10% -$27.4K
LBRDA icon
1805
Liberty Broadband Class A
LBRDA
$5.17B
$247K ﹤0.01%
3,094
OPI
1806
DELISTED
Office Properties Income Trust
OPI
$247K ﹤0.01%
33,786
-22,382
-40% -$119K
AXSM icon
1807
Axsome Therapeutics
AXSM
$11.4B
$246K ﹤0.01%
3,112
EVC icon
1808
Entravision Communication
EVC
$1.08B
$246K ﹤0.01%
59,202
+4,920
+9% +$19.5K
XENE icon
1809
Xenon Pharmaceuticals
XENE
$6.21B
$244K ﹤0.01%
5,341
+848
+19% +$30K
NVRO
1810
DELISTED
NEVRO CORP.
NVRO
$243K ﹤0.01%
11,341
OR icon
1811
OR Royalties Inc
OR
$6.32B
$239K ﹤0.01%
16,813
CHWY icon
1812
Chewy
CHWY
$9.25B
$237K ﹤0.01%
10,088
-8,170
-45% -$161K
FRPH icon
1813
FRP Holdings
FRPH
$415M
$236K ﹤0.01%
7,540
WSBC icon
1814
WesBanco
WSBC
$4B
$235K ﹤0.01%
7,522
-880
-10% -$23.6K
BKCC
1815
DELISTED
BlackRock Capital Investment Corporation
BKCC
$235K ﹤0.01%
61,287
-10,849
-15% -$39.5K
PLUG icon
1816
Plug Power
PLUG
$2.94B
$234K ﹤0.01%
52,321
-151,373
-74% -$794K
CNA icon
1817
CNA Financial
CNA
$13.9B
$233K ﹤0.01%
5,518
-17,782
-76% -$724K
GTX icon
1818
Garrett Motion
GTX
$5.41B
$233K ﹤0.01%
24,259
HDB icon
1819
HDFC Bank
HDB
$120B
$233K ﹤0.01%
6,956
-21,724
-76% -$655K
RELY icon
1820
Remitly
RELY
$4.87B
$233K ﹤0.01%
12,086
+1,215
+11% +$27.2K
UEC icon
1821
Uranium Energy
UEC
$5.63B
$231K ﹤0.01%
36,264
BBSI icon
1822
Barrett Business Services
BBSI
$783M
$230K ﹤0.01%
8,000
MCS icon
1823
Marcus Corp
MCS
$921M
$230K ﹤0.01%
15,791
-5,826
-27% -$87.3K
TAC icon
1824
TransAlta
TAC
$3.88B
$228K ﹤0.01%
27,640
+5,061
+22% +$40.9K
IMAX icon
1825
IMAX
IMAX
$2.81B
$227K ﹤0.01%
15,239

Similar funds

Canada Life's Q4 2023 Portfolio in Review

As of Q4 2023, Canada Life held 2,251 positions worth $45.5B, up 9.3% from $41.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Canada Life withdrew a net $3.11B in Q4 2023, closing 90 positions and reducing 1,035 holdings. Its most notable exit was Activision Blizzard, an estimated $59.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Canada Life opened a new position in Jazz Pharmaceuticals worth $9.89M.

  • Canada Life's largest Q4 2023 buy was Jazz Pharmaceuticals: 80,654 shares worth $9.89M.
  • Canada Life added most to AbbVie in Q4 2023, an estimated $59.4M increase.
  • Canada Life's biggest Q4 2023 reduction was TSMC, cutting an estimated $968M.
  • Canada Life fully exited Activision Blizzard in Q4 2023, selling an estimated $59.1M.
  • Canada Life's ten largest holdings make up 23% of its $45.5B portfolio in Q4 2023.
  • Canada Life opened 17 new positions and closed 90 in Q4 2023.
  • Canada Life's portfolio value rose 9.3% quarter-over-quarter to $45.5B.

Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.